How much weight can you lose in the first 3 months on semaglutide or tirzepatide?

Most patients lose approximately 5–10% of their body weight in the first 3 months. For a 250 lb person, that's roughly 12–25 lbs. Results accelerate as the dose increases and appetite suppression intensifies.

Why am I not losing weight on semaglutide or tirzepatide?

Slow or stalled weight loss can result from being in the titration phase, a dose that needs adjustment, dietary factors, metabolic conditions, or inconsistent administration. Contact your DietsMD physician — most cases can be addressed with dose optimization or lifestyle adjustments.

Will I regain weight if I stop taking semaglutide or tirzepatide?

Research shows most patients regain a significant portion of lost weight within 12 months of stopping GLP-1 medications. This is why DietsMD focuses on long-term maintenance planning — including maintenance dosing and lifestyle integration — as part of every patient's program.

GLP-1 Weight Loss Results: What to Expect Month by Month (Semaglutide & Tirzepatide)

Medically reviewed by DietsMD Board-Certified Physicians, Obesity Medicine

Ready to start your GLP-1 journey? Take our free eligibility quiz and get reviewed by a licensed physician.

Take the Free Quiz →

HIPAA compliant | No commitment required | Results in minutes

One of the most common questions patients have before starting GLP-1 therapy is: how fast will I lose weight, and how much? The honest answer is that results vary by individual — but clinical trial data gives us a powerful benchmark. These results are based on patients enrolled in our online medical weight loss program using GLP-1 medications. The majority of patients are prescribed semaglutide for weight loss, the most clinically studied GLP-1 therapy available. This guide breaks down exactly what to expect, month by month, based on the best available science from the STEP (semaglutide) and SURMOUNT (tirzepatide) clinical trials.

Q: How fast do you lose weight on semaglutide or tirzepatide?
A: Most patients notice appetite suppression within the first 1–2 weeks. Measurable weight loss typically begins by weeks 4–8, with significant results by months 3–6. Clinical trials show average losses of 15% (semaglutide) and 20.9% (tirzepatide) of body weight over 68–72 weeks.

Month-by-Month Results Overview

Weeks 1–4 (Titration Phase): Starting at the lowest dose. Most patients notice reduced appetite within the first 1–2 weeks. Weight loss during this phase is typically modest (2–5 lbs) as the body adjusts.

Months 2–3: Dose increases begin. Appetite suppression becomes more pronounced. Average weight loss of 5–10% body weight is common by the end of month 3.

Months 4–6: The most significant weight loss phase for most patients. Many reach 10–15% body weight loss. Energy levels often improve as metabolic health improves.

Months 7–12: Weight loss continues but may slow. Plateau management through dose optimization and lifestyle adjustments becomes important. Many patients reach 15–22% body weight loss by month 12.

Semaglutide Results: Clinical Trial Data

From the landmark STEP clinical trial program:

Average weight loss: 15% of body weight over 68 weeks
86% of patients lost 5% or more of body weight
69% of patients lost 10% or more of body weight
50% of patients lost 15% or more of body weight

Tirzepatide Results: Clinical Trial Data

From the SURMOUNT clinical trial program:

Average weight loss: 20.9% of body weight over 72 weeks
Up to 22.5% at the highest dose (15mg)
Compared to 3.1% with placebo

What Affects Your Results?

Starting weight — higher starting BMI often correlates with greater absolute weight loss
Dose — higher maintenance doses generally produce greater weight loss
Adherence — consistent weekly dosing is critical for results
Diet and activity — GLP-1 medications work without diet changes, but lifestyle habits improve outcomes
Medical supervision — proper titration and monitoring optimize results and minimize side effects

Q: What results can I realistically expect from GLP-1 therapy?
A: Based on clinical trial data, most patients can expect 10–22% body weight loss over 6–12 months with consistent use under medical supervision. Individual results vary based on dose, adherence, and metabolic factors.

Frequently Asked Questions

Q: How much weight can I lose in the first month on semaglutide?
A: Most patients lose 2–5 lbs in the first month, primarily due to appetite suppression at the starting dose. Weight loss accelerates as the dose increases in months 2–3.

Q: Does tirzepatide work faster than semaglutide?
A: Both medications follow similar titration schedules. Tirzepatide generally produces greater total weight loss over time, but the pace of early weight loss is comparable.

Q: What happens if I hit a plateau?
A: Plateaus are common and manageable. Your physician may adjust your dose, recommend dietary modifications, or evaluate other factors. Ongoing medical supervision is key to breaking through plateaus.

Q: Will I regain weight after stopping GLP-1 medications?
A: Research shows most patients regain weight after discontinuation. This is why DietsMD focuses on long-term maintenance planning alongside active treatment.

This page has been medically reviewed by DietsMD board-certified physicians specializing in obesity medicine. Clinical data referenced is sourced from the STEP and SURMOUNT clinical trial programs.